期刊档案 · MEDICINE, RESEARCH & EXPERIMENTAL

Precision Clinical Medicine

ISSN 2096-5303 · eISSN 2516-1571 · Oxford University Press · United Kingdom

Precision Clinical Medicine 中科院 医学 2区(2025 年升级版),影响因子 8.7(官网公布),完全开放获取,APC 约 2,000 美元,近 24 个月 76 篇文章投稿到接收中位 55 天,2025 年发文 40 篇,ESCI、Scopus 收录。

影响因子8.7期刊官网公布的 2025 年度值
中科院分区医学 2区2025 年升级版大类 · 2026 新锐版 医学 2区
审稿周期55 天投稿到接收中位数 · 近 24 个月 76 篇文章 · PubMed
版面费2,000 USD完全开放获取
录用比例—暂无反馈
年发文量40 篇2025 年 · OpenAlex 统计

研究范围

研究范围与定位

Precision Clinical Medicine 由 Oxford University Press 出版,属中科院医学大类(2025 升级版2区)。按 OpenAlex 近年发文统计,该刊主要发表 Cancer Immunotherapy and Biomarkers、Gut microbiota and health、SARS-CoV-2 and COVID-19 Research 等主题的论文,这 3 个主题约占 21.1%。(根据 OpenAlex 主题统计与中科院分区数据生成)

Precision medicine, a new model of medicine that tailors healthcare to individual characteristics, is revolutionizing all areas of health and disease. These characteristics include genomic information as well as molecular, cellular, and image profiling and beyond, based on which individuals can be classified into subpopulations for specialized decision in the treatment and management of a disease. Precision medicine is one of the most exciting and promising frontiers in medicine, which holds the greatest potential in the discovery, development and application of precision prevention, diagnostics, therapeutics and prognostics. Such prospects necessitate concerted efforts from multi-disciplinary research and clinical experience in almost all fields of medicine to improve patient outcomes. Platforms are also required for the interaction of all involved knowledge to help healthcare professionals and researchers in the world exchange ideas, technologies, discoveries and experiences in applying precision medicine. Precision Clinical Medicine (PCM) commits itself to the combination of precision medical research and clinical application. PCM is a peer-reviewed, open access journal that publishes original research articles, case reports, reviews, editorials and perspectives on all aspects in the field of precision medicine in a timely manner. By doing so, the journal aims to provide new theories, methods, and evidence for disease diagnosis, treatment, prevention and prognosis, so as to establish a communication platform for clinicians and researchers that will impact practice of medicine. The journal covers all aspects of precision medicine, which uses novel means of diagnosis, treatment and prevention tailored to the needs of a patient or a sub-group of patients based on the specific genetic, phenotypic, or psychosocial characteristics. Clinical conditions include cancer, infectious disease, inherited diseases, complex diseases, rare diseases, etc. Topics include but not limited to the following: Genetics, cytogenetics, epigenetics Genomics, proteomics, and metabolomics, radiomics, pharmacogenomics, etc. Bioinformatics and computational biology Biomarker studies Molecular classification of diseases Medical imaging Novel technologies (eg. 3D printing, liquid biopsy, artificial intelligence for medicine, digital medicine) New applications of traditional technologies Regulatory, ethical and economic issues in precision medicine Abstracting and Indexing Precision Clin

摘自期刊官网 Aims & Scope

研究方向(LetPub):MEDICINE, RESEARCH & EXPERIMENTAL

主编 Weimin Li出版商官网

编委会国家分布:中国大陆 35 位(约 44%);主要国家 中国 35、美国 29、英国 8、加拿大 2、澳大利亚 2(共 80 位编委标注了国家) 编委会 ↗出版商官网 ·

主要研究主题 OpenAlex 近年发文统计,占比为近似值

  1. Cancer Immunotherapy and BiomarkersMedicine8.3%
  2. Gut microbiota and healthBiochemistry, Genetics and Molecular Biology6.4%
  3. SARS-CoV-2 and COVID-19 ResearchMedicine6.4%
  4. Cancer Genomics and DiagnosticsBiochemistry, Genetics and Molecular Biology6.4%
  5. COVID-19 Clinical Research StudiesMedicine6%
  6. MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology5.3%
  7. Radiomics and Machine Learning in Medical ImagingMedicine5.3%
  8. Immune Cell Function and InteractionImmunology and Microbiology4.2%

分区与收录

学科分区与数据库收录

中科院期刊分区表

期刊分区表( 2025年3月升级版)医学 2 区
类别学科分区
大类医学2 区
小类医学:研究与实验MEDICINE, RESEARCH & EXPERIMENTAL2 区

Top 期刊:否综述期刊:否

《新锐期刊分区表》( 2026年3月发布)医学 2 区
类别学科分区
大类医学2 区
小类医学:研究与实验MEDICINE, RESEARCH & EXPERIMENTAL2 区

Top 期刊:否综述期刊:未标注

期刊分区表( 2023年12月旧的升级版)医学 4 区
类别学科分区
大类医学4 区
小类医学:研究与实验MEDICINE, RESEARCH & EXPERIMENTAL4 区

Top 期刊:否综述期刊:否

数据库收录

ESCIScopusDOAJLetPub

国际期刊预警名单:各版本均未列入LetPub

期刊官网自述收录

PMCEmbase出版商官网

其他:EBSCO

期刊官网列出的收录清单,未与各数据库逐一核对;Web of Science 各子库以上方记录为准。

不同版本、大类与小类分别展示,不将不同评价口径合并为一个分区值;投稿与考核前请确认所在机构采用的版本。

指标

影响力指标与发文规模

影响力指标

影响因子(出版商公布) 2025
8.7出版商官网 ·
五年影响因子(出版商公布) 2025
5.5出版商官网 ·
CiteScore 2026-06
8.7LetPub ·
CiteScore(出版商公布) 2025
8.7出版商官网 ·
SJR 2026-06
1.66LetPub ·
SNIP 2026-06
1.25LetPub ·
h-index
37OpenAlex ·
i10-index
134OpenAlex ·
两年平均被引
6.17OpenAlex ·
自引率
7.8%LetPub ·
Gold OA 文章占比
100%LetPub ·

发文规模

年文章数
29LetPub ·
年下载量(出版商公布) 2025
136,421出版商官网 ·

逐年发文量 OpenAlex 统计 · 累计 283 篇 · 当年数据不完整

年份发文量其中 OA被引
2026292924
20254040237
20243434374
20233434407
20223030663
20213030808

不同来源的统计口径与观测时间不同,页面保留各来源原值;“出版商公布”为期刊官网自述数据。

审稿与录用

审稿周期与录用情况

文章统计的审稿周期 PubMed 登记的稿件日期 · 至

55 天投稿到接收中位数 · P25–P75 34 天 – 80 天

接收到上线
中位数 3 天(76 篇)
投稿到上线
中位数 65 天
样本
76 篇有投稿与接收日期的文章(窗口内共 80 篇),最近一篇接收于

只统计最终被录用并发表的文章,不含被拒稿件的处理时间,因此通常长于出版商公布的"首次决定时间"。

其他来源

平均审稿速度(社区反馈)
5 WeeksLetPub ·
投稿到发表(期刊自报)
约 5 周DOAJ ·
评审方式
单盲同行评审DOAJ

社区反馈来自投稿者样本,置信度 0.5,不代表期刊承诺;“出版商公布”的时间节点定义以官网为准。

费用与开放获取

版面费与开放获取政策

完全开放获取DOAJ

所有文章开放获取,通常向作者收取文章处理费(APC)。

来源文章处理费费用减免许可证观测时间
DOAJUSD 2,000无CC BY、CC BY-NC
OpenAlexUSD 2,000——
LetPub无文章处理费无—
出版商官网USD 3,625——

其他费用与减免(作者指南)

费用优惠
20
投稿费
USD 3,625

费用以期刊官网为准;不同来源的观测时间可能不同,页面保留各来源原值,不做平均。

投稿要求

文章类型与投稿政策(官网)

投稿准备要点1 项,摘自作者指南
图文摘要
可选
出版商官网 · 模型提取,逐项与原文核对
接收的文章类型7 种
  1. case reportManuscript Type Definition Research Article Word limit*: ≥3000 Abstract: Structured and no more than 250 words Figures and/or tables: ≤8 Description: Research a…未说明篇幅
  2. commentaryManuscript Type Definition Research Article Word limit*: ≥3000 Abstract: Structured and no more than 250 words Figures and/or tables: ≤8 Description: Research a…未说明篇幅
  3. opinionManuscript Type Definition Research Article Word limit*: ≥3000 Abstract: Structured and no more than 250 words Figures and/or tables: ≤8 Description: Research a…未说明篇幅
  4. original researchManuscript Type Definition Research Article Word limit*: ≥3000 Abstract: Structured and no more than 250 words Figures and/or tables: ≤8 Description: Research a…未说明篇幅
  5. research articleManuscript Type Definition Research Article Word limit*: ≥3000 Abstract: Structured and no more than 250 words Figures and/or tables: ≤8 Description: Research a…未说明篇幅
  6. reviewManuscript Type Definition Research Article Word limit*: ≥3000 Abstract: Structured and no more than 250 words Figures and/or tables: ≤8 Description: Research a…未说明篇幅
  7. review articleManuscript Type Definition Research Article Word limit*: ≥3000 Abstract: Structured and no more than 250 words Figures and/or tables: ≤8 Description: Research a…未说明篇幅
出版商官网
官网政策摘录利益冲突、数据可用性、许可与版权、开放获取、同行评审、查重、预印本
利益冲突 Conflict of interest

牛津大学出版社要求在在线投稿时声明任何利益冲突;如果稿件发表,利益冲突信息将以声明形式在发表的论文中传达。 模型中文摘要

Oxford University Press requires declaration of any conflict of interest upon submission online. If the manuscript is published, conflict of interest information will be communicated in a statement in the published paper.

原文 ↗出版商官网 ·
数据可用性 Availability of Data and Materials

在伦理可行的情况下,《Precision Clinical Medicine》强烈鼓励作者向读者提供论文结论所依赖的所有数据和软件代码,建议将数据呈现在主稿或补充文件中,或尽可能存入公共存储库。 模型中文摘要

Where ethically feasible, Precision Clinical Medicine strongly encourages authors to make all data and software code on which the conclusions of the paper rely available to readers. We suggest that data be presented in the main manuscript or additional supporting files, or deposited in a public repository whenever possible. For information on general repositories for all data types, and a list of …

原文 ↗出版商官网 ·
许可与版权 Third-party copyright

为在文章中复制任何第三方材料(包括表格、图片或图像),作者必须获得版权持有者的许可并遵守其有关该复用的任何要求;请求复制时应索取非独占复制权、印刷与电子权、作品存续期使用权以及全球英语使用权。 模型中文摘要

In order to reproduce any third party material, including tables, figures, or images, in an article authors must obtain permission from the copyright holder and be compliant with any requirements the copyright holder may have pertaining to this reuse. When seeking to reproduce any kind of third party material authors should request the following: non-exclusive rights to reproduce the material in t…

原文 ↗出版商官网 ·
开放获取 Third-party content in Open Access papers

如果论文以开放获取许可发表但包含作者没有开放获取复用许可的材料,作者须在该材料旁提供注明内容标题、作者、原始出版物、原始发表年份及版权持有者的致谢行,并声明该图像/内容不受本出版物知识共享许可条款约束、复用请联系权利持有者。 模型中文摘要

If you will be publishing your paper under an Open Access licence but it contains material for which you do not have Open Access re-use permissions, please state this clearly by supplying the following credit line alongside the material: Title of content. Author, Original publication, year of original publication, by permission of [rights holder]. This image/content is not covered by the terms of …

原文 ↗出版商官网 ·
同行评审 Peer Review

该期刊实行单盲同行评审,作者身份对编辑和审稿人公开,而审稿人身份仅编辑知晓并对作者隐藏;所有投稿先由一名编辑初审,稿件可能因优先级不高或与期刊不相关而未经同行评审即被拒稿。 模型中文摘要

This journal operates single-anonymised peer review, meaning that the Authors identity is known to the Editor and to the Reviewers, but that the Reviewers’ identities are known only to the Editor and are hidden from the Authors. For full details about the peer review process, see Fair editing and peer review. All submissions to the journal are initially reviewed by one of the Editors. At this stag…

原文 ↗出版商官网 ·
查重 Plagiarism

投给《Precision Clinical Medicine》的稿件可能使用iThenticate反剽窃软件进行筛查,以检测和防止剽窃;任何稿件都可能被筛查,尤其是有理由认为部分或全部文本已发表过的稿件,最终接受前未筛查的稿件也可能进行iThenticate筛查。 模型中文摘要

Manuscripts submitted to Precision Clinical Medicine may be screened with iThenticate anti-plagiarism software in an attempt to detect and prevent plagiarism. Any manuscript may be screened, especially if there is reason to suppose part or all of the text has been previously published. Prior to final acceptance any manuscript that has not already been screened may be put through iThenticate. More …

原文 ↗出版商官网 ·
预印本 Preprint policy

作者保留通过多种渠道提供作者原始版本(预印本)的权利,且这不影响向期刊投稿;如被接受,作者须按作者自存档政策页面所述更新任何预印本的状态,包括已发表论文的DOI。 模型中文摘要

Authors retain the right to make an Author’s Original Version (preprint) available through various channels, and this does not prevent submission to the journal. For further information see our Online Licensing, Copyright and Permissions policies. If accepted, the authors are required to update the status of any preprint, including your published paper’s DOI, as described on our Author Self-Archiv…

原文 ↗出版商官网 ·

摘录来自期刊官网页面,仅保留原文片段;“模型摘要”由 Workers AI 生成并经原文校验,以官网为准。

基本信息

出版信息与官方入口

出版商
Oxford University Press
出版国家或地区
United Kingdom
出版语言
English
ISSN
2096-5303
电子版 ISSN
2516-1571
官网最新一期
Volume 9, Issue 3(2026 年 9 月)
官方链接

常见问题

关于 Precision Clinical Medicine 的常见问题

Precision Clinical Medicine 是中科院几区期刊?

2025 年升级版分区表中,Precision Clinical Medicine 为医学 2区,小类 医学:研究与实验 2 区。2026 年新锐版分区表中为医学 2区。不同版本与大小类分区不能混用。

Precision Clinical Medicine 的影响因子是多少?

期刊官网公布的影响因子为 8.7(2025 年度),属期刊自述数据,LetPub 暂无该刊的影响因子记录,CiteScore 为 8.7,h-index 为 37。

Precision Clinical Medicine 的审稿周期多长?

按 2024年10月至2026年10月(近 24 个月)76 篇已发表文章登记的日期,投稿到接收的中位数为 55 天(四分位 34–80 天);投稿社区反馈的平均审稿速度为约 5 周。文章统计只含被录用的稿件,出版商数据口径以官网为准,社区反馈来自投稿者样本,均不代表期刊承诺。

Precision Clinical Medicine 的编委会里有中国学者吗?

期刊官网编委会页面上标注了国家的 80 位编委中,中国大陆 35 位(约 44%);人数最多的国家是 中国(35 位)、美国(29 位)、英国(8 位)。统计按编委会页面列出的机构国家计,仅供参考。

Precision Clinical Medicine 被哪些数据库收录?

据 LetPub 与 DOAJ 记录,Precision Clinical Medicine 被 ESCI、Scopus、DOAJ 收录。期刊官网自述还被 PMC、Embase 收录,该清单未与各数据库逐一核对。

Precision Clinical Medicine 是开放获取期刊吗?版面费多少?

Precision Clinical Medicine 为完全开放获取。APC 约 2,000 美元。

来源与更新

本页事实来自 LetPub、OpenAlex、DOAJ、出版商官网;每个数字旁标注来源与观测日期,冲突数据保留各来源原值。LetPub 原始详情页:查看 ↗(2026-08-26 归档)。最近更新:。